AIM: To assess the impact of the 5-fluorouracil (5-FU) drug-pathway genes on cytotoxicity, and determine whether loss-of-function analyses coupled with functional assays can help prioritize pharmacogenomic candidate genes. MATERIALS & METHODS: Dose-response experiments were used to quantify the phenotype of sensitivity to 5-FU following the specific knockdown of genes selected from the 5-FU PharmGKB drug pathway in three human colorectal cell lines. Changes in sensitivity were considered significant if the IC(50) for shRNA-exposed cells were three standard deviations outside the mean IC(50) for control-treated cells. RESULTS: Of the 24 genes analyzed, 13 produced significant changes on the phenotype of sensitivity to 5-FU (DHFR, DPYS, DTYMK, DUT, FPGS, GGH, NME1, NT5C, RRM1, TYMS, UCK2, UNG and UMPS). CONCLUSION: The RNAi screening strategy enabled prioritization of the genes from the 5-FU drug pathway. Further validation of the genes credentialed in this study should include gene activity or expression and mutation analyses of clinical samples.
AIM: To assess the impact of the 5-fluorouracil (5-FU) drug-pathway genes on cytotoxicity, and determine whether loss-of-function analyses coupled with functional assays can help prioritize pharmacogenomic candidate genes. MATERIALS & METHODS: Dose-response experiments were used to quantify the phenotype of sensitivity to 5-FU following the specific knockdown of genes selected from the 5-FU PharmGKB drug pathway in three human colorectal cell lines. Changes in sensitivity were considered significant if the IC(50) for shRNA-exposed cells were three standard deviations outside the mean IC(50) for control-treated cells. RESULTS: Of the 24 genes analyzed, 13 produced significant changes on the phenotype of sensitivity to 5-FU (DHFR, DPYS, DTYMK, DUT, FPGS, GGH, NME1, NT5C, RRM1, TYMS, UCK2, UNG and UMPS). CONCLUSION: The RNAi screening strategy enabled prioritization of the genes from the 5-FU drug pathway. Further validation of the genes credentialed in this study should include gene activity or expression and mutation analyses of clinical samples.
Authors: Elizabeth A Kidd; Jinsheng Yu; Xia Li; William D Shannon; Mark A Watson; Howard L McLeod Journal: Clin Cancer Res Date: 2005-04-01 Impact factor: 12.531
Authors: Christiane Jakob; Torsten Liersch; Wolfdietrich Meyer; Gustavo B Baretton; Peter Häusler; Wolfgang Schwabe; Heinz Becker; Daniela E Aust Journal: Am J Surg Pathol Date: 2005-10 Impact factor: 6.394
Authors: C G Leichman; H J Lenz; L Leichman; K Danenberg; J Baranda; S Groshen; W Boswell; R Metzger; M Tan; P V Danenberg Journal: J Clin Oncol Date: 1997-10 Impact factor: 44.544
Authors: Tian-Li Wang; Luis A Diaz; Katharine Romans; Alberto Bardelli; Saurabh Saha; Gennaro Galizia; Michael Choti; Ross Donehower; Giovanni Parmigiani; Ie-Ming Shih; Christine Iacobuzio-Donahue; Kenneth W Kinzler; Bert Vogelstein; Christoph Lengauer; Victor E Velculescu Journal: Proc Natl Acad Sci U S A Date: 2004-02-17 Impact factor: 11.205
Authors: Holly R Thomas; Hany H Ezzeldin; Vincenzo Guarcello; Lori K Mattison; Brooke L Fridley; Robert B Diasio Journal: Pharmacogenet Genomics Date: 2008-01 Impact factor: 2.089
Authors: Jolien Tol; Miriam Koopman; Annemieke Cats; Cees J Rodenburg; Geert J M Creemers; Jolanda G Schrama; Frans L G Erdkamp; Allert H Vos; Cees J van Groeningen; Harm A M Sinnige; Dirk J Richel; Emile E Voest; Jeroen R Dijkstra; Marianne E Vink-Börger; Ninja F Antonini; Linda Mol; Johan H J M van Krieken; Otilia Dalesio; Cornelis J A Punt Journal: N Engl J Med Date: 2009-02-05 Impact factor: 91.245
Authors: James Cassidy; Leonard B Saltz; Bruce J Giantonio; Fairooz F Kabbinavar; Herbert I Hurwitz; Ulrich-Peter Rohr Journal: J Cancer Res Clin Oncol Date: 2009-11-11 Impact factor: 4.553
Authors: John P Vanden Heuvel; Jerry T Thompson; Prajakta Albrecht; Donald Mandetta; Harry Kamerow; John P Ford Journal: Invest New Drugs Date: 2015-07-01 Impact factor: 3.850
Authors: Nathaniel Melling; Masoud Rashed; Cornelia Schroeder; Claudia Hube-Magg; Martina Kluth; Dagmar Lang; Ronald Simon; Christina Möller-Koop; Stefan Steurer; Guido Sauter; Frank Jacobsen; Franziska Büscheck; Corinna Wittmer; Till Clauditz; Till Krech; Maria Christina Tsourlakis; Sarah Minner; Hartwig Huland; Markus Graefen; Lars Budäus; Imke Thederan; Georg Salomon; Thorsten Schlomm; Waldemar Wilczak Journal: Int J Mol Sci Date: 2017-01-29 Impact factor: 5.923
Authors: Oluf Dimitri Røe; Adam Szulkin; Endre Anderssen; Arnar Flatberg; Helmut Sandeck; Tore Amundsen; Sten Even Erlandsen; Katalin Dobra; Stein Harald Sundstrøm Journal: PLoS One Date: 2012-08-08 Impact factor: 3.240